Merger Transaction and Acquisition - Schedule of Equity Instruments Outstanding (Details) - shares shares in Thousands	Dec. 31, 2025	Dec. 31, 2024	Aug. 21, 2024
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Common stock, shares outstanding (in shares)	148,055	60,091
Total shares (in shares)			87,185
Series A Cumulative Convertible Preferred Stock Subject To Possible Redemption
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Payment-in-kind percentage of series A cumulative convertible preferred stock subject to possible redemption	12.00%	12.00%
Common Stock
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Common stock, shares outstanding (in shares)	148,055	60,091	81,952
Preferred Stock
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Total shares (in shares)			5,233
Pre-merger shares \| Common Stock
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Common stock, shares outstanding (in shares)			60,273
Pre-merger shares \| Preferred Stock
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Total shares (in shares)			4,318
Shares issued in reverse merger recapitalization \| Common Stock
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Common stock, shares outstanding (in shares)			21,679
Shares issued in reverse merger recapitalization \| Preferred Stock
Merger Transaction - Schedule of Equity Instruments Outstanding (Details) [Line Items]
Total shares (in shares)			915